differentiation, pathogen-primed Th17 cells maintain a high degree of heterogeneity and 48 plasticity. Further analysis identified caspase-1 as one of the genes upregulated only in 49 pathogen-primed Th17 cells but not in cytokine-polarized Th17 cells. T-cell-intrinsic caspase-1, 50 independent of its function in inflammasome, is critical for inducing optimal pathogen-driven 51
T cells in vitro. 107
To study the transcriptional regulation of pathogen-specific CD4 T cell during 108 differentiation, we sought to design and validate an in vitro priming system to mimic in vivo 109 priming of naïve CD4 T cells following microbial infections. We posited that in vitro priming would 110 allow the identification and characterization of all pathogen-specific CD4 T cells at various stages 111 of differentiation. In addition, we predicted that we would be able to determine the specificity of 112 the generated responses. Dendritic cells, both migratory and lymphoid organ resident, play a 113 central role in T cell differentiation (3). Therefore, a simple, isolated system that contains core 114 elements required for T cell priming: dendritic cells, naïve CD4 T cells and complex components 115 from pathogens, should allow the differentiation of pathogen-specific CD4 T cells. Similar co-116 culture approaches have been reported previously for the activation of human and mouse CD4 117 T cells (15) (16) (17) (18) (19) (20) . More recent work has elegantly demonstrated that exposure of human 118 monocytes to different pathogens leads to priming of pathogen-specific CD4 T cells, whose 119 effector cytokines are dictated by the priming pathogen (15, 21) . However, concerns are that 120 these studies used peripheral blood monocytes or bone-marrow derived dendritic cells (BMDCs), 121 which are composed of a heterogeneous mixture of macrophages and 'myeloid' DCs with distinct 122 antigen presentation abilities (22) (23) (24) . These populations have been shown to deviate from 123 lymphoid and tissue-resident DC populations (22) . Furthermore, the pathogen specificity and 124 functionality of the primed T cells in the previous studies was not fully established (17) (18) (19) (20) 25) . 125
We designed the in vitro system based on human studies using monocytes but instead 126 using splenic CD11c + DCs (Flt3l-dependent, ex vivo) as antigen-presenting cells (APCs) to 127 prime naïve CD4 T cells isolated from spleen and peripheral lymph nodes ( Fig. 1A) (15) . Whole-128 cell lysates of bacteria including diverse PAMPs and proteins were used as PRR stimuli and 129 T cells that failed to undergo expansion (CFSE + CD90 + ) remained in naïve state and did not 139 produce effector cytokines (Fig. 1B, upper right) . In contrast to non-specific polyclonal priming 140 mediated by CD3 ligation in the presence of LPS stimulated DCs, we observed a binary 141 distribution between CFSEcells undergoing division and static CFSE + T cells ( Fig. S1B) , 142
indicating clonal expansion of a small proportion of T cells. A large proportion of static CFSE hi 143 cells suggested a very low frequency of naïve T cells to have undergone active priming (Fig. 144 S1B) . Accordingly, generation of in vitro pathogen-primed T cells required pMHC-II:TCR 145 interaction and costimulation, as well as innate cytokine milieu (for example, IL-12 for generation 146 of IFNγ+ cells) ( Fig. S1C and S1D) thus ruling out the possibility of antigen-independent, 147 inflammatory cytokine-driven T cell proliferation (26). 148
In vitro priming system generates pathogen-dictated CD4 T cell responses 149
To test whether this approach can induce differentiation of functional effector CD4 T cells 150 in vitro, we took advantage of three well-studied mouse pathogens: Listeria monocytogenes (Lm), 151
Citrobacter rodentium (Cr), and Staphylococcus aureus (Sa). The level of proliferation of CD4 T 152 cells primed by different pathogen lysates was comparable ( Fig. S1E ). However, CFSE -CD4 T 7 cells exhibited distinct cytokine profiles: Cr-primed T cells generated significantly more IL-17A + 154 population compared to both Lm and Sa; Lm-priming generated predominantly IFNg-producing 155 CD4 T cells and Sa-stimulated DCs primed both IFNg + and IL-17A + CD4 T cells (Fig. 1C ). This 156 was also evident when we measured these cytokines in the supernatants (Fig. 1D ). Th1/Th17 157 profile observed in the in vitro system are in concordance with the dominant responses 158 previously reported for each pathogen in vivo (27) (28) (29) . Live infection of DCs with these pathogens 159 also led to similar Th1/Th17 profile as lysates and therefore we used bacterial lysates for rest of 160 the study to be consistent for antigen dosage and concentration or PRR ligands ( Fig. S1C) . 161
We sorted the total CFSE -CD4 T cell population from Lm-and Cr-primed cultures and 162 performed mRNA sequencing to compare their global transcriptional profiles ( Fig. 1E ). Cr-primed 163 T cells revealed a Th17-associated gene signature, while Lm-primed T cells predominantly 164 contained a high level of Th1-associated transcripts. Notably, 126 genes were uniquely 165 expressed in Lm-primed T cells and 233 genes were uniquely expressed in Cr-primed T cells, 166 when normalized to their CFSE + naive counterparts ( Fig. 1E ; Table S3 ), indicating pathogen-167 associated T cell transcriptome. These experiments established that dendritic cells, exposed to 168 a complex mixture of pathogen proteins and PRR ligands, can indeed prime naïve CD4 T cells 169 in vitro. More importantly, depending on the nature of the pathogenic stimuli, DCs were able to 170 shape distinct CD4 T cell transcriptional profiles. 171
In vitro pathogen-primed T cells are specific to the priming pathogen 172
To interrogate whether these in vitro primed T cells were specific to the priming pathogen, 173
we first examined TCR repertoire enrichment by comparing CFSEprimed cells to CFSE + naïve 174 pool ( Fig. S2A ). We observed a selective enrichment of TCR Vβ10,12,14 and 15 in CFSE -175 population. Meanwhile, expression of Vβ13-3, 20, 26 was diluted in CFSEpopulation, indicating 176 a lack of proliferation of these Vβ-expressing T cells in response to Lm (Fig. S2A ). To measure 8 specificity, we rested pathogen-primed CD4 T cells and then restimulated these cells in vitro with 178 irradiated, pathogen lysate fed B cells. We found that primed and rested CD4 T cells secreted 179
IFNg and IL-17A only when re-stimulated by B cells exposed to the original priming pathogen 180 ( Fig. 2A and S2B ). Cytokine production and upregulation of T cell activation markers (CD25, 181 CD69, ICOS and CD44) were dependent on the dose of lysates used for reactivation, further 182 confirming the specificity of the responding T cells ( Fig. 2A-B and S2B-C). In contrast, 183 restimulation with the non-priming (mismatched) pathogen did not lead to cytokine secretion at 184 any of the doses used ( Fig. 2A-B and S2B-C), further establishing the specificity of the response. 185
Using a similar mismatch scheme ( Fig. 2C ), we further tested whether in vitro primed CD4 186
T cells respond to infection by the priming pathogen in vivo. To that end, we transferred Lm-or 187
Cr-primed CD45.2 + T cells to CD45.1 + congenic, immune competent recipients and recipients 188 were challenged with intraperitoneal Lm infection 48 hours after transfer ( Fig. 2C and S2D ). Mice 189 that received pathogen-primed CD4 T cells but were not subsequently infected with 190 L.monocytogenes served as baseline controls. Donor CD4 T cells proliferated in response to 191 matched pathogen re-challenge (Lm-primed donor cells and Lm infection; Fig. 2C ) but did not 192 respond to mismatched pathogen re-challenge (Cr-primed donor cells and Lm infection) in the 193 spleen ( Fig. 2D ) and lymph nodes ( Fig. S2E ). In addition, matched re-challenge induced 194 significant upregulation of cell surface ICOS expression on donor cells ( Fig. 2E ). ICOS 195 upregulation on recipient CD45.1 + CD4 T cells was unaffected by the transfer of Lm-or Cr-196 primed T cells ( Fig. 2E and S2F ). It is important to note here that we used a very low dose of Lm 197 for challenge and responses were assessed shortly after infection that precluded the possibility 198 of de novo priming of naïve CD4 T cells in the recipient. In summary, these data allow us to 199 conclude that the in vitro priming system generates effector T cells bearing TCRs that are likely 200 to be reactive to peptides derived from the original priming pathogen. 201
Pathogen-primed Th17 cells are comprised of heterogeneous subsets and display a 202 transcriptional profile different from cytokine-polarized Th17 cells. 203
Among all the effector T cell lineages, Th17 cells have been reported to have a high 204 degree of plasticity and heterogeneity (30). They are sensitive to variations in polarizing 205 cytokines between distinct microenvironments (31), and can convert to regulatory subsets during 206 the resolution of inflammation (32). This intrinsic fine-tuning of Th17 cells makes them an ideal 207 effector lineage to dissect their transcriptional regulation during pathogen-induced differentiation. 208
We generated mice that would allow fate-mapping of CD4 T cells that commit to making IL-17A 209 Table S4 ). Pathway analysis revealed that ppTh17 cells expressed high levels 223
of genes related to diverse T cell effector functions while cdTh17 cells upregulated cell cycle-224 and proliferation-related genes ( Fig. 3C and Table S5 ). Consistently, cdTh17 cells exhibited a 225 strongly activated phenotype characterized by the extremely high expression of Th17-lineage 226 master TFs Rorc, Rora and Ahr and the enhanced expression of Th17 lineage cytokines Il17a, 227
Il17f and Il22 (Fig. 3D ). In addition, cdTh17 cells significantly upregulated Il9, known to further 228 promote Th17 lineage (34) (Fig. 3D ). In contrast, ppTh17 cells exhibited a multi-lineage 229 phenotype by expressing an array of Th1 and Th2-associated genes, such as transcription factor 230 T-bet (Tbx21), GATA3 (Gata3) and cytokines (IFNg, Il4, Il5, Il13) , representing potential lineage 231 plasticity (35) (Fig. 3D ). Interestingly, cdTh17 cells expressed a high level of transcription factor 232 cells previously committed to Th17 lineage (Fig. 3E ). The proportion of this population increased 239 as the cells proliferated over an extended period of differentiation (from day 5 to day 10) ( Fig.  240   3E) . In contrast, cdTh17 cells did not re-express YFP, even after the removal of polarizing 241 cytokines ( Fig. 3E ). Although studies have shown polarized Th17 cells are able to transit to Th1 242 cells upon secondary stimulation (37, 38) , our data indicate that plasticity during primary 243 commitment is limited in cdTh17 cells. 244
Further analysis of the transcriptome revealed that ppTh17 cells upregulated a set of 245 genes encoding membrane-associated proteins that are important for chemotaxis ( Fig. 3F , Table  246 S5), including chemokine receptors (Ccr1 and Cxcr3), extracellular matrix metalloproteases 247 (Mmp7 and Mmp9), myosins (Myo1f and Myo1g), S1P receptor family (S1pr1 and S1pr4) and 248 G-protein-coupled receptor EBI2 (Gpr183) ( Fig. 3F and Table S6 ) (39) (40) (41) (42) . Interestingly, we also 249 found highly enriched interferon-stimulated genes (ISGs) in naïve and ppTh17s ( Fig. S3C ), as 250 IFI16 (Ifi204) and STING-activation has been demonstrated to mediate anti-proliferative effect 251 in CD4 T cells and promote memory formation (43). We sought to determine whether transcripts 252 of ppTh17s denote the acquisition of memory T cell state. Comparison of metabolic gene 253 datasets indicates that ppTh17 cells upregulated AMPK pathway, fatty acid oxidation and 254 oxidative phosphorylation programs that maintain memory T cell function ( Fig. 3G) (44, 45) ; 255 cdTh17 cells upregulated c-Myc and HIF1α targets and resemble terminally differentiated 256 effector T cells that employ glycolysis as energy fuel (Fig. 3G) (46) (47) (48) . Consistently, ppTh17 257 expressed genes upregulated in memory T cells, such as Il7r and Il15ra (Fig. S3D) , which are 258 important for the maintenance of memory T cells through IL-7R and IL-15R signaling (49, 50) . 259
To further test our hypothesis on a global transcriptional landscape, we performed gene set 260 enrichment analysis (GSEA) with memory versus effector T cell molecular signature from 261
ImmuneSigDB database (51). GSEA analysis indicated that memory T cell-associated genes 262
were enriched in ppTh17s compared to cdTh17s (Fig. 3H, upper) . Effector T cell-associated 263 genes were enriched in cdTh17s, consistent with their metabolic status ( Fig. 3G and H, lower; 264 Table S7 ). 265
We further validated some highly upregulated genes in ppTh17 compared to cdTh17 by 266 quantitative RT-PCR ( Fig. S3E ). Since the experiments so far have focused on identifying 267 distinct transcriptional profiles between pathogen-primed or cytokine-polarized CD4 T cells in 268 vitro, we also assessed the physiological relevance of our findings. We infected the 17A-fm 269
reporter mice with C. rodentium, sorted total CD4 + tdTomato + cells (consist of differentiated, Cr-270 specific Th17 cells) from mesenteric lymph nodes (mLNs) at the peak of infection, and assessed 271 the expression of these key variable genes ( Fig. S3E and S3F ). The majority of the genes tested 272 had comparable expressions between CD4 + tdTomato + cells and ppTh17 cells. Furthermore, 273
unsupervised hierarchical clustering showed that ppTh17s resembled in vivo effector Th17 cells 274 ( Fig. S3F) , indicating a close functional relationship between ppTh17 cells and in vivo generated 275
Th17 cells during infection. 276
In summary, we find that in contrast to cytokine-polarized Th17 lineage cells that display Our analysis ( Fig. 3B-D) and some other evidence suggest DCs directly modulate the 282 heterogeneity and plasticity of Th17 cells (15). Whether DCs regulate Th17 responses through 283 the expression of specialized regulators is still unclear (52). To identify such regulators, we 284 focused on genes that would be uniquely expressed in ppTh17 but not in cdTh17 cells. 285
Surprisingly, Casp1 (encoding caspase-1) emerged as an interesting candidate, with 5-to 10-286 fold induction of expression in ppTh17 cells compared to cdTh17 cells or naïve T cells ( Fig. 4A  287 and S3E). We also found that Casp1 is upregulated in ex vivo effector T cell population primed 288 in mLNs following C. rodentium infection (Fig. S3F ). Caspase-1 and caspase-11 (gene name as 289 Casp4) are inflammatory caspases that have overlapping effector functions downstream of 290 inflammasome activation primarily in myeloid cells (53, 54) . However, the role of these caspases 291 in T cells is not well defined. Casp1 and Casp4 transcripts are upregulated in memory T cells 292 compared to naïve T cells in Immgen database (www.immgen.org; Fig. S4A ). However, Casp4 293 levels are not significantly different between ppTh17 and cdTh17 ( Fig. 4A and S4B) , indicating 294 that Casp4 may be upregulated upon TCR activation but Casp1 is induced in T cells by unknown 295 cues from DCs. 296
To test whether DC-induced caspase-1 plays a role in pathogen-specific Th17 297 differentiation, we used Casp1Δ10 mice which specifically lack the expression of caspase-1 but 298 not caspase-11 (55). We found Casp1Δ10 T cells to be defective in Th17 differentiation following 299 in vitro priming with Cr-stimulated WT DCs (Fig. 4C and D) . Commitment to Th1 or Th2 lineages 300 13 in Casp1Δ10 CD4 T cells was unaffected (Fig. 4E ). There was no difference in proliferation 301 between WT and Casp1Δ10 T cells during in vitro priming (Fig. S4C) . These results suggest a 302 highly critical role for T-cell-intrinsic caspase-1 in inducing optimal Th17 response during 303 pathogen-mediated differentiation. 304
Caspase-1 functions in CD4 T cells independently of its canonical enzymatic activity or 305 inflammasome activation 306
The role of caspase-1 in inducing pyroptotic cell death in HIV-infected CD4 T cells has 307 been previously demonstrated (56, 57) . However, the role of T-cell-intrinsic caspase-1 in normal 308 CD4 T cell differentiation is still unclear. When we examined the expression pattern of Casp1 309 transcripts during differentiation, we found that Casp1 mRNA increased temporally, correlating 310 with the increase of IL-17A-fm-tdTomato signal ( Fig. 4F and S4D) . Similarly, we found caspase-311 1 protein to be expressed highly after day 7 post stimulation and is maintained through day 12 312 with the highest levels expressed in CFSEdifferentiated population (Fig. 4G-H and S4E) . 313
However, in primed T cells, we did not find cleaved caspase-1 p20, an active product resulted 314 from inflammasome activation in macrophages ( Fig. 4G-H) . The absence of cleaved form 315 suggests that the role of caspase-1 in CD4 T cells could be independent of its canonical function 316 in the inflammasome complex as an IL-1 cleaving enzyme (58). Consistent with this idea, we did 317 not observe a defect in Cr-induced priming in Asc -/and Il1b -/-CD4 T cells (Fig. 4I) . IL-1β, 318 secreted following inflammasome activation, has been shown to promote Th17 responses in 319 vivo (59). However, supplementing IL-1α or IL-1β to Casp1Δ10 T cells cultures failed to rescue 320 the defect in IL-17A + cell differentiation (Fig. S4F ), suggesting a function for caspase-1 that is 321 independent of its IL-1β cleavage activity. 322
Given that we did not observe cleaved caspase-1 in CD4 T cells, we looked into a possibly 323 catalytically-independent function of caspase-1. Caspase activation and recruitment domain 324 (CARD) of caspase-1 facilitates homeostatic binding to effector proteins such as ASC and RIP2 325 (54) . Binding of caspase-1 to RIP2 through CARD, for example, promotes NF-kB signaling 326 independent of its enzymatic activity (60). To test the possible scaffolding function of caspase-327 1, we ectopically reconstituted Casp1Δ10 CD4 T cells with full-length (FL), CARD-deficient 328 (ΔCARD) or enzymatically inactive (EnzDead) caspase-1 and investigated their ability to induce 329
Th17 lineage commitment (Fig. S4G) . Reconstitution of FL and EnzDead caspase-1 resulted in 330 an increase of IL-17A-producing T cells compared to vector alone but ΔCARD failed to promote 331
Th17 differentiation (Fig. 4J) . EnzDead caspase-1 led to modestly enhanced Th17 differentiation 332 than FL-caspase-1, suggesting that inhibiting catalytic activity might promote functions 333 associated with the CARD domain of caspase-1 (Fig. 4J ). Overall these data provide compelling 334 evidence that T-cell-intrinsic caspase-1, in an inflammasome-independent fashion, promotes 335
Th17 differentiation. 336
T-cell-intrinsic caspase-1 is required for Th17-mediated disease in vivo. 337
Even though we found that absence of T-cell-intrinsic caspase-1 affected the generation 338 of pathogen primed Th17 cells, TCR activation-and cytokine cocktail-driven Th17 polarization 339 ( Fig. S5A ) and proliferation (Fig. S5B ) was unaffected. This prompted us to examine the in vivo 340 relevance of our findings. By analyzing steady-state T helper cell populations in co-housed WT 341
and Casp1Δ10 mice, we found reduced IL-17A + % (Fig. S5C) and IL-22 + % (Fig. S5D ) CD4 T 342 cells in the spleen, mLN and small intestine lamina propria (LP) of Casp1Δ10 mice, consistent 343 with previous reports (61). The percentage of IFNγ-producing CD4 T cells was unchanged in 344 mLN and LP but increased in the spleens of Casp1Δ10 mice (Fig. S5E ). Since these outcomes 345 could be a result of caspase-1 deficiency in myeloid cells, we further investigated the role of T 346 cell autonomous caspase-1 in vivo by using a T cell transfer model of colitis. In this approach, 347 highly purified naïve CD4 T cells from WT and Casp1Δ10 mice are transferred to Rag1 -/-348 recipients thus restricting the genetic deficiency to the CD4 T cell compartment. Since 349 transferred naïve CD4 T cells differentiate in response to components of gut microbiota and 350 germ-free mice develop a very mild disease (62, 63), this approach would allow us to test the 351 significance of our in vitro priming system. 352
We found that Rag1 -/animals that received Casp1Δ10 naïve CD45RB hi CD4 T developed 353 very mild disease when compared to WT T cell recipient mice that developed measurable colitis, 354 including significant weight loss (Fig. 5A ) and disease progression (Fig. 5B) . Recipients of WT 355 T cells also showed significant colon shortening compared to non-T cell transferred controls (Fig.  356   5C ). However, transfer of Casp1Δ10 T cells did not lead to this disease manifestation (Fig. 5C ). 357
Transfer of WT T cells also led to severe colonic pathology, marked by transmural infiltration of 358 leukocytes, epithelial cell hyperplasia and submucosal morphological changes, while transfer of 359
Casp1Δ10 naïve T cells induced significantly less leukocyte infiltration and morphological 360
changes associated with colitis ( Fig. 5D and S5F) . We observed significantly lower IL-17A + IFNγ + 361 in mLNs and colons of Casp1∆10 T cell recipients compared to WT T cell recipients (Fig. 5E) . 362
These IL-17A + IFNγ + pathogenic Th17 cells have been demonstrated to be critical for the 363 induction of T cell mediated-colitis and development of pathology (10). Of note, there was no 364 difference in the proportion of IL-17A + IFNγnon-pathogenic population between WT and 365
Casp1Δ10 recipients (Fig. S5G) . In contrast, we observed the significantly less splenic 366 expansion of total IL-17A + Casp1Δ10 cells (Fig. 5F) , consistent with the reduced circulating IL-367
17A levels throughout the course of the disease (Fig. 5G ). Overall these data support that T-368 cell-intrinsic caspase-1 selectively controls the differentiation of both pathogen-specific and auto-369 inflammatory Th17 lineage cells. Furthermore, even though cells of both innate and adaptive 370 immune system express caspase-1, these data provide compelling evidence for a distinct role 371 for caspase-1 in regulating Th17 biology. 372
Discussion 373
Although dominant and protective CD4 T cell responses to specific pathogens are well 374 understood, transcriptional profiling of newly differentiated pathogen-specific CD4 T cells, 375
following in vivo infections, has been lacking due to the absence of tools to identify all responding 376 CD4 T cells. A recent method has highlighted an in vitro priming and de novo differentiation of 377 naïve pathogen-specific human CD4 T cells by autologous pathogen-stimulated monocytes (15, 378 21) . This isolated priming system is freed from the use of exogenous polarizing cytokines and 379 strong or repeated antigenic exposure, allowing mapping of a primary, pathogen-specific CD4 T 380 cell response. Combining the in vitro priming system with genetic fate-mapping and RNA-381 sequencing, we were able to track and profile the differentiation of murine pathogen-specific 382 CD4 T cells. Consistent with previous studies, we found that while CD4 T cells primed against a 383 particular pathogen differentiate into one dominant effector lineage, other subtypes also co-exist 384 (Fig. 1C-E) (5, 15) . In addition, transcriptional analysis of fate-mapped Th17 cells suggests the 385 existence of multiple sub-lineages (Th2/Th17, IL-10-or GM-CSF-secreting populations) ( Fig.  386   3D) . The heterogeneity of the T cell response is presumably dictated by DCs encountering a 387 complex mixture of PAMPs unique to each pathogen (3). But why and how only certain bacteria 388 species induce Th17 cells still remains unclear. In addition to C.rodentium, several other 389 mucosal pathogens (e.g. EHEC) and commensals (e.g. Segmented Filamentous Bacteria) favor 390 a Th17-dominant response, and this ability was attributed to their interaction with distinct 391 intestinal microenvironments (31, (64) (65) (66) (67) . Interestingly, we observed that both live Cr-and Cr 392 lysate-stimulated splenic CD11c + DCs are sufficient to induce Th17 cells (Fig. 1C and S1F) , 393
suggesting that in addition to the unique mucosal microenvironment, evolutionarily conserved 394 ligands in certain gut-associated bacteria could promote a Th17 response. The molecular 395 mechanisms that drive this tailored response require further investigation. 396
Our data suggest that DCs influence transcriptional programming of T cells that extends 397 beyond activation and effector cytokine production. CD4 T cells differentiated by pathogen-398 stimulated DCs showed transcriptional profiles that display lineage plasticity and features of 399 memory differentiation (Fig. 3) . DC-dependent programming also promotes CD4 functional 400 heterogeneity and expression of genes associated with of T cell migration and motility (Fig. 3) . 401
In line with our idea that DC-induced transcriptome contains context-specific genes that fine-402 tune CD4 T cell response, we found induction of caspase-1 only in T cells that were primed by 403 pathogen-stimulated DCs. Our data also firmly establish that caspase-1, independent of its role 404 in inflammasome activation and IL-1β production, plays a T-cell-intrinsic role for the 405 differentiation of Th17 lineage cells. Perplexingly, cytokine-mediated polarization of Th17 cells 406 neither induce caspase-1 nor need caspase-1 for optimal differentiation, thus highlighting the 407 fact that these cells might not resemble physiologically generated Th17 cells. The results from 408 the T cell transfer model of colitis extended the role of caspase-1 to the differentiation of auto-409 inflammatory Th17 cells. Our data also redefine the role of caspase-1 in Th17-mediated 410 inflammatory disease in vivo. Earlier studies have reported that caspase-1 knockout animals 411 have ameliorated disease in several chronic autoimmune models (68-70). At the time this was 412 attributed to abrogated IL-1β and IL-18 production during inflammasome activation in myeloid 413 cells (69, 71). Our results suggest the possibility that T-cell-intrinsic deficiency of caspase-1 414
impairing Th17 commitment could have also contributed to the phenotypes. Since the majority 415 of the studies on inflammasome components harnessed whole body deficient mice, further 416 efforts would be necessary to dissect the specific roles of caspase-1 in innate and adaptive 417 immune compartments in regulating T cell differentiation and Th17-associated disease 418
outcomes. 419
Despite the report that the effector function of human Th1 cells is enhanced by 420 complement-driven, caspase-1-dependent inflammasome activation within CD4 T cells (72), we 421 observed a moderately increased Th1 commitment in Casp1Δ10 T cells in mouse ( Fig. 4E and  422   S5E ). Importantly, we demonstrated that the role of caspase-1 in controlling Th17 differentiation 423 is independent of its enzymatic activity and depends on its CARD domain. Recent work has 424
shown that caspase-1 is expressed but dispensable for IL-1β production in Th17 cells (73), as 425 we found no difference in the ability of full-length or enzymatically inactive caspase-1 in driving 426
Th17 differentiation. Additionally, caspase-1 seems to have a critical function for regulating Th17 427 differentiation by possibly interacting with other proteins in the cytosol using its CARD domain. 428
A variety of proteins have been reported to contain core CARD domains, such as BCL10 and 429 AIRE (74, 75), posing a wide possibility for the interaction partners for caspase-1. The putative 430
interaction partner itself may also be regulated by an appropriate differentiation signal, in order 431 for caspase-1 to function only in DC-mediated Th17 priming. Evolutionarily, caspase-1 in early 432 vertebrates lacks the ability to cleave IL-1 (76), suggesting a possible regulatory trait of these 433 proteins. Indeed, other CARD-containing proteins have important roles beyond the involvement 434 in inflammatory and apoptotic cell death, particularly in linking T cell receptor activation to 435 signaling cascade (77). 436
The current approaches used to study T cell priming and differentiation in vivo depend on 437 TCR transgenic models or identification of epitope-specific T cells by pMHC tetramers (78). The 438 in vitro differentiation method relies on the use of anti-CD3/CD28 antibodies and exogenous 439 recombinant cytokines (4, 12, 13) . These three approaches, although very informative, fail to 440 address the diverse specificity of TCRs or the heterogeneity of the responses. Additionally, since 441 specific signals received by a naïve CD4 T cell during a critical window of differentiation are likely 442 to dictate its fate, it is tempting to speculate that cytokine-driven T cell differentiation, although 443 important for the analysis of certain aspects of T cell biology, deviates considerably from a 444 physiological immune response. The in vitro priming approach described here enables the study 445 of the antigen-specific CD4 T cell differentiation using physiological levels of stimulation provided 446 by DCs to generate multi-lineage and oligoclonal pathogen-specific T cells. Furthermore, genetic 447 manipulations can be used to explore the roles of molecular pathways in both CD4 T cells and 448
DCs that will open avenues for detailed mechanistic studies. 449
Approaches using DCs and other APCs to prime antigen-specific CD4 and CD8 T cells 450 have been explored in both human and mouse studies (15, 79) . However, our studies using the 451 murine system have allowed us to establish the specificity and also reveal the in vivo relevance 452 of these in vitro primed T cells. Notably, we have used splenic DCs as APCs, which are 453 predominately composed of CD11c + CD11band CD11c + CD11b + populations (80). This is 454 currently a limitation of our study and future efforts could focus on using specific DC 455 subpopulations to dissect their impact on dictating transcriptional profile of responding CD4 T 456 cells. Additionally, it would be worthwhile to also use tissue resident or migratory DC populations 457 when investigating CD4 T cell responses to tissue invading or compartmentalized pathogens. 458
Tissue-resident DCs, for example, lamina propria CD103 + DCs, may generate distinct T cell 459 responses and transcriptional profiles that are relevant to mucosal immunity (31, 81) . 460
Taken together, our work highlights a novel workflow for studying pathogen-specific CD4 461 T cell differentiation. Conceptually, the dataset from this study provides experimental evidence 462 for the importance of dendritic cells in dictating global transcriptional programming of antigen-463 specific CD4 T cells. Integration of a systems biology approach into this in vitro priming system 464 empowers high-throughput analysis of anti-microbial T cell responses to discover novel players 465 (such as caspase-1) in CD4 T cell activation and differentiation. 466 
